Evaluation of the Effect of Benzonatate on QT Intervals Following Single Dose Administration of Benzonatate to Healthy Volunteers

NCT02207699 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Benzonatate 200 mg
DRUG: Benzonatate 800 mg
DRUG: Moxifloxacin 400 mg
DRUG: Placebo

Sponsor

Pfizer